The FDA panel has decided to recommend booster shots at this stage only for 65+ and other high risk groups. https://www.yahoo.com/entertainment/...203847937.html
It sounds like expert opinion is somewhat divided on the case for booster shots, and maybe also on the mixing of vaccines. That is not surprising because it involves weighing the risks of giving approval when there may be incomplete information against the potential benefits in combating the pandemic. Even with the same clinical information, different experts might come to different judgements on that balance. "Following the science" doesn't always give a clear-cut answer.
I understand that it is generally desirable for the regulators to be able to make decisions without political pressure, although a degree of pressure is unavoidable because of the consequences. The FDA were under a lot of political pressure to give early approval to vaccines last year. Maybe that was undesirable, but if there had been no pressure would they have been as willing to give emergency approval as early as they did?
My sense is that regulators are generally inclined to err on the side of caution because the consequences are asymmetric. If they approve and there are problems they get the blame, but if they don't approve then nobody sees the counterfactual. Sometimes this can cause problems.
For example, the advisory panel in Australia contributed to vaccine hesitancy earlier this year through their advice on AstraZeneca, which was then the only widely available vaccine here. The problem was that their advice seemed to focus too narrowly on the very low risk of blood clots from AZ, and not enough on the broader risks of Covid. As a result, we've struggled to deal with the Delta outbreak over the past 2-3 months because the initial vaccination rate was low.